long-term efficacy of nivolumab combinations in advanced escc in checkmate 648
Published 2 months ago • 35 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:19
29-month follow-up from checkmate 648: nivolumab combination therapy in escc
-
3:05
checkmate 648: novel treatment for patients with advanced esophageal squamous cell carcinoma
-
4:59
checkmate 648: 1l io-io in advanced esophageal squamous cell carcinoma
-
1:44
checkmate 649: nivolumab and chemotherapy or ipilimumab in gc/gejc/eac
-
4:58
long-term results from checkmate 040: nivolumab ipilimumab in advanced hcc
-
9:32
checkmate 648: nivolumab plus ipilimumab or nivo plus chemo versus chemo as (1l) treatment for a...
-
1:22
3-year follow-up of checkmate 649: nivolumab chemotherapy in gc/gejc/eac
-
1:02
long-term benefits of the dcf regimen in the jcog1109 trial for esophageal cancer
-
4:47
nivolumab chemotherapy combination treatment: checkmate649 and attraction-4
-
1:48
checkmate 205: 5 year follow-up of nivolumab in hl
-
5:31
checkmate-227: nivolumab ipilimumab in mnsclc
-
2:29
checkmate 205: does nivolumab improve the long-term outcomes of patients with advanced stage chl?
-
3:13
attraction-3: nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinoma
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
11:36
emerging data with immunotherapy in esophageal squamous cell carcinoma
-
6:10
deliver: nivolumab in advanced gastric cancer
-
3:12
nivolumab for perioperative esophageal and gastroesophageal cancer: checkmate 577
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
3:52
checkmate 025: phase 3 trial of nivolumab for advanced kidney cancer